---
title: Capturing Patient Voice to Improve Outcomes That Matter to Patients with Desmoid
  Tumor
date: '2024-06-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38863992/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240612181856&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Desmoid tumors (DT) are rare, intermediate-grade sarcomas characterized
  by locally aggressive growths that commonly occur intra-abdominally, in the abdominal
  wall, or in the extremities. Desmoid tumors are 2-3-fold more common in females
  than males, with most patients aged <40 years at diagnosis. Clinical course of DT
  is highly variable but rarely fatal, with median overall survival >80% at 20 years.
  However, patient morbidity and DT symptom burden can be high. DT significantly reduce
  ...
disable_comments: true
---
Desmoid tumors (DT) are rare, intermediate-grade sarcomas characterized by locally aggressive growths that commonly occur intra-abdominally, in the abdominal wall, or in the extremities. Desmoid tumors are 2-3-fold more common in females than males, with most patients aged <40 years at diagnosis. Clinical course of DT is highly variable but rarely fatal, with median overall survival >80% at 20 years. However, patient morbidity and DT symptom burden can be high. DT significantly reduce ...